E-LIB Suche - Ergebnisse für: Deluche, E.

1

7P Trastuzumab deruxtecan (T-DXd) for advanced breast cance..:

Dieras, V.C. ; André, F. ; Lusque, A....
ESMO Open. 9 (2024) - p. 103016 , 2024

Link: https://doi.org/10.1016/..

2

Dépistage du déficit en dihydropyrimidine déshydrogénase (D..:

Calderon, C. ; Maillan, G. ; Deluche, E..
Le Pharmacien Clinicien. 59 (2024) 2 - p. e142 , 2024

Link: https://doi.org/10.1016/..

3

Efficacy of administration sequence: Sacituzumab Govitecan ..:

Poumeaud, F. ; Morisseau, M. ; Cabel, L....
British Journal of Cancer. , 2024

Link: https://doi.org/10.1038/..

4

205P Trastuzumab biosimilar (TB) in combination with pertuz..:

Freyer, G. ; Petit, I. ; Comte, A....
ESMO Open. 9 (2024) - p. 103227 , 2024

Link: https://doi.org/10.1016/..

5

121TiP LESS: Single-arm study to de-escalate adjuvant endoc..:

Deluche, E. ; Michiels, S. ; Fric, D....
ESMO Open. 8 (2023) 1 - p. 101345 , 2023

Link: https://doi.org/10.1016/..

6

Compliance to genomic test recommendations to guide adjuvan..:

Hequet, D. ; Hajjaji, N. ; Charafe‐Jauffret, E....
Cancer Medicine. 12 (2023) 16 - p. 16889-16895 , 2023

Link: https://doi.org/10.1002/..

7

ACACIAS 1: The physiological and subjective impacts of high..:

Deluche, E. ; Salle, H. ; Leobon, S....
Journal of Visceral Surgery. 160 (2023) 5 - p. 323-329 , 2023

Link: https://doi.org/10.1016/..

8

HSD63 New Pathway in Anti-HER2 Treatments' Administration i..:

Pozzar, M. ; Couillerot, A.L. ; Gherardi, A....
Value in Health. 26 (2023) 12 - p. S305-S306 , 2023

Link: https://doi.org/10.1016/..

9

Study of sarcopenia according to the criteria of mass, musc..:

Salacroup, C. ; David, C. ; Fayemendy, P....
Clinical Nutrition ESPEN. 58 (2023) - p. 443 , 2023

Link: https://doi.org/10.1016/..

10

Efficacité et facteurs prédictifs de la réponse à l'immunot..:

Ilie, M. ; Villa, C. ; Cuny, T....
Annales d'Endocrinologie. 83 (2022) 5 - p. 312 , 2022

Link: https://doi.org/10.1016/..

11

Étude de la sarcopénie selon les critères de masse, de forc..:

Salacroup, C. ; David, C. ; Fayemendy, P....
Nutrition Clinique et Métabolisme. 36 (2022) 1 - p. S60 , 2022

Link: https://doi.org/10.1016/..

12

Predictors of women's attendance in a home-based adapted ph..:

Deveautour-Roy, E. ; Tubiana-Mathieu, N. ; Léobon, S....
Supportive Care in Cancer. 30 (2022) 12 - p. 10223-10231 , 2022

Link: https://doi.org/10.1007/..

13

A prolactinoma resistant to cabergoline: The important role..:

Salle, L. ; Deluche, E. ; Géraud, F..
Revue Neurologique. 177 (2021) 9 - p. 1202-1205 , 2021

Link: https://doi.org/10.1016/..

14

Evolution of overall survival and receipt of new therapies ..:

Grinda, T. ; Antoine, A. ; Jacot, W....
ESMO Open. 6 (2021) 3 - p. 100114 , 2021

Link: https://doi.org/10.1016/..

15

Indice de masse corporelle et pronostic du cancer du sein :..:

Fayemendy, C. ; Jésus, P. ; Fayemendy, P....
Nutrition Clinique et Métabolisme. 34 (2020) 1 - p. 71 , 2020

Link: https://doi.org/10.1016/..